Evaluation of the effectiveness of platelet-rich plasma in the treatment of Asherman's syndrome
Not Applicable
- Conditions
- Asherman syndrome.Intrauterine synechiaeN85.6
- Registration Number
- IRCT20200316046789N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Clinical diagnosis of Asherman's syndrome
Age: 18 to 43 years old
Informed consent to participate in the study
Exclusion Criteria
Simultaneous infection of the uterus and vagina
Hemoglobin less than 11
Platelet less than 150,000
History of anticoagulant use
Dissatisfaction with entering the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method terine adhesion grade. Timepoint: 6 to 8 weeks later hysteroscopy. Method of measurement: Histroscopy.
- Secondary Outcome Measures
Name Time Method